US Prime Magazine

Business

HDFC Bank posts 22.30% jump in Q2, consolidated net at ₹11,125 cr

John

[ad_1]

HDFC Bank on Saturday reported a 22.30% jump in its consolidated net profit for the September quarter at ₹11,125.21 crore. The bank had reported a consolidated net profit of ₹9,096.19 crore in the year-ago period.

On a standalone basis, the largest private sector bank’s net profit rose by over 20% to ₹10,605.78 crore as against ₹8,834.31 crore in the year-ago period and ₹9,196 crore in the preceding June quarter.

For the reporting quarter, its total income rose to ₹46,182 crore from ₹38,754 crore in the year-ago period, while the expenditure, excluding provisions and contingencies, climbed to ₹28,790 crore from ₹22,947 crore, the bank said.

The overall share of gross non-performing assets improved to 1.23% of the book as against 1.35% in the year-ago period and 1.28% three months ago.

Catch all the Corporate news and Updates on Live Mint.
Download The Mint News App to get Daily Market Updates & Live Business News.

More
Less

[ad_2]

Source link

Related Posts

Oaktree, Hinduja, Cosmea, Torrent among 9 bidders for Reliance Capital

[ad_1] MUMBAI : Nine entities, including US private equity major Oaktree Capital, Torrent group, Hinduja group, and a consortium of Piramal group and Cosmea Financial Holdings have submitted final bids for the whole of Reliance Capital and its subsidiaries, two people aware of the matter said. Monday was the last date for submitting the final […]

HCL Tech posts 7.1% rise in Q2 profit; lifts sales, Ebit guidance

[ad_1] The Shiv Nadar-founded company increased its FY23 revenue expectations to 13.5-14.5% from the 12-13% range earlier, while it expects to stay in the Ebit margin range of 18-19% now, compared to 18-20% earlier. Constant currency growth came in at 15.8% y-o-y. The company has guided for a 16-17% IT services Ebit margin for this […]

Recession fears save pharma from drug-pricing concerns

[ad_1] Premium Some pharmaceutical companies, including Pfizer, are looking to mergers and acquisitions for strength ahead of prescription-drug price cuts later this decade. (Photo: AP) 3 min read . Updated: 26 Sep 2022, 04:56 PM IST David Wainer, The Wall Street Journal Manufacturers are facing patent expirations and price pressure, but investors […]